|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02126 JW THERAP-B
Nominal 
1.420 +0.050 (+3.650%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (398,418) | (536,722) | (561,198) | (261,005) |
| Net Cash from / (used in) Investing Activities | -- | 9,904 | (124,083) | (137,130) | (91,909) |
| Net Cash from / (used in) Financing Activities | -- | 275 | 112,354 | (30,621) | 2,859,427 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (388,239) | (548,451) | (728,949) | 2,506,513 |
| Cash & Cash Equivalents at beginning of period | -- | 1,383,336 | 1,834,399 | 2,630,598 | 254,866 |
| Effect of Foreign Exchange Rate Changes | -- | 10,812 | 97,388 | (67,250) | (130,781) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,005,909 | 1,383,336 | 1,834,399 | 2,630,598 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -240,267,000 |
| %Change | -36.841% |
| EPS / (LPS) | RMB -0.580 |
| NBV Per Share (¥) | RMB 3.570 |